An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma

por Izutsu, Koji, Makita, Shinichi, Nosaka, Kisato, Yoshimitsu, Makoto, Utsunomiya, Atae, Kusumoto, Shigeru, Morishima, Satoko, Tsukasaki, Kunihiro, Kawamata, Toyotaka, Ono, Takaaki, Rai, Shinya, Katsuya, Hiroo, Ishikawa, Jun, Yamada, Hironori, Kato, Kazunobu, Tachibana, Masaya, Kakurai, Yasuyuki, Adachi, Nobuaki, Tobinai, Kensei, Yonekura, Kentaro, Ishitsuka, Kenji
Publicado 2023

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II...

por Armand, Philippe, Engert, Andreas, Younes, Anas, Fanale, Michelle, Santoro, Armando, Zinzani, Pier Luigi, Timmerman, John M., Collins, Graham P., Ramchandren, Radhakrishnan, Cohen, Jonathon B., De Boer, Jan Paul, Kuruvilla, John, Savage, Kerry J., Trneny, Marek, Shipp, Margaret A., Kato, Kazunobu, Sumbul, Anne, Farsaci, Benedetto, Ansell, Stephen M.
Publicado 2018

Nivolumab for classical Hodgkin lymphoma after autologous stem-cell transplantation and brentuximab vedotin failure: a prospective phase 2 multi-cohort study

por Younes, Anas, Santoro, Armando, Shipp, Margaret, Zinzani, Pier Luigi, Timmerman, John M, Ansell, Stephen, Armand, Philippe, Fanale, Michelle, Ratanatharathorn, Voravit, Kuruvilla, John, Cohen, Jonathon B, Collins, Graham, Savage, Kerry J, Trneny, Marek, Kato, Kazunobu, Farsaci, Benedetto, Parker, Susan M, Rodig, Scott, Roemer, Margaretha GM, Ligon, Azra H, Engert, Andreas
Publicado 2016